Please assess the completion status of the following clinical trial:

Trial Title: Mirtazapine Versus Placebo in Functional Dyspepsia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Functional dyspepsia according to Rome II criteria~* Weight loss of \> 5% body weights~Exclusion Criteria:~* Organic GI pathology~* History of upper gi tract surgery~* Major depression or anxiety~* Use of antidepressants in the last 2 months~* Prokinetic drugs or spasmolytic drugs~* Analgesic use (except paracetamol)~* Pregnancy or lactation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Mirtazapine (Type: ACTIVE_COMPARATOR): mirtazapine 15 mg daily
- Placebo (Type: PLACEBO_COMPARATOR): Placebo once daily

Based on this trial design, predict the completion outcome and termination type (if applicable).